Coronavirus Accentuates Existing Problems in America’s Health Care System

Editorial & Advertiser Disclosure Global Banking And Finance Review is an independent publisher which offers News, information, Analysis, Opinion, Press Releases, Reviews, Research reports covering various economies, industries, products, services and companies. The content available on globalbankingandfinance.com is sourced by a mixture of different methods which is not limited to content produced and supplied by various staff writers, journalists, freelancers, individuals, organizations, companies, PR agencies Sponsored Posts etc. The information available on this website is purely for educational and informational purposes only. We cannot guarantee the accuracy or applicability of any of the information provided at globalbankingandfinance.com with respect to your individual or personal circumstances. Please seek professional advice from a qualified professional before making any financial decisions. Globalbankingandfinance.com also links to various third party websites and we cannot guarantee the accuracy or applicability of the information provided by third party websites. Links from various articles on our site to third party websites are a mixture of non-sponsored links and sponsored links. Only a very small fraction of the links which point to external websites are affiliate links. Some of the links which you may click on our website may link to various products and services from our partners who may compensate us if you buy a service or product or fill a form or install an app. This will not incur additional cost to you. A very few articles on our website are sponsored posts or paid advertorials. These are marked as sponsored posts at the bottom of each post. For avoidance of any doubts and to make it easier for you to differentiate sponsored or non-sponsored articles or links, you may consider all articles on our site or all links to external websites as sponsored . Please note that some of the services or products which we talk about carry a high level of risk and may not be suitable for everyone. These may be complex services or products and we request the readers to consider this purely from an educational standpoint. The information provided on this website is general in nature. Global Banking & Finance Review expressly disclaims any liability without any limitation which may arise directly or indirectly from the use of such information.

On March 13th, the Kaiser Family Foundation released a brief that delves into the costs surrounding COVID-19. The findings highlight the steep expenses that may plague employer health plans and their enrollees. Although many insurers are covering some testing and treatments, the costs associated with hospitalizations are not being waived, leaving a large group of employees and their dependents vulnerable to astronomical medical bills. These costs could potentially surpass $20,000 per employee.

For many members of the general public, this may seem like an issue that were just now uncovering. However, this comes as no surprise to those with a career in health care, like James Napoli, JD, CEO of Medliminal. Mr. Napoli has his own thoughts on how the virus has impacted health care costs, stating, Although the health care costs associated with COVID-19 are a new challenge that will impact many Americans, medical bill overcharges have been troubling our society long before COVID-19 came along.

Medliminal is a medical cost containment company that deals with medical billing errors and overcharges on a daily basis. Medical debt has become the number one cause of bankruptcy in America, and yet, over 90% of medical bills contain billing errors, Mr. Napoli reveals. With the machine learning capabilities of their proprietary technology, H-CAT„¢, combined with their experienced nurses and coding team, Medliminal identifies billing errors for their clients, including large corporations, insurance companies, employers, as well as the individual consumer.

Medliminals Senior Director of Hospital Division, Brian Echols, is continuing to work with his team to provide health care consumers with the newest innovations in medical cost containment. Medliminal is closely following recommendations from the CDC and CMS regarding coding and billing guidance for health care encounters related to the Coronavirus outbreak, Mr. Echols disclosed. Our team of professionals will continue to make the necessary changes to our claim review process to ensure our clients receive expert review of their medical charges.

With years of experience and their team of experts, Medliminal has positioned itself to be at the forefront in the containment of health care costs associated with the Coronavirus. To learn more, visit www.medliminal.com.

Devin Wood – [email protected]